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Guy J. Clarkson,a Daniel McFeely,b Abraha Habtemariam,a Luca Salassa,cde
Vasilios G. Stavros,a Christopher G. Dowson*b and Peter J. Sadler*a
The novel photoactive ruthenium(II) complex cis-[Ru(bpy)2(INH)2][PF6]2 (1$2PF6, INH ¼ isoniazid) was
designed to incorporate the anti-tuberculosis drug, isoniazid, that could be released from the Ru(II)
cage by photoactivation with visible light. In aqueous solution, 1 rapidly released two equivalents of
isoniazid and formed the photoproduct cis-[Ru(bpy)2(H2O)2]
2+ upon irradiation with 465 nm blue
light. We screened for activity against bacteria containing the three major classes of cell envelope:
Gram-positive Bacillus subtilis, Gram-negative Escherichia coli, and Mycobacterium smegmatis in
vitro using blue and multi-colored LED multi-well arrays. Complex 1 is inactive in the dark, but when
photoactivated is 5.5 more potent towards M. smegmatis compared to the clinical drug isoniazid
alone. Complementary pump-probe spectroscopy measurements along with density functional
theory calculations reveal that the mono-aqua product is formed in <500 ps, likely facilitated by
a 3MC state. Importantly, complex 1 is highly selective in killing mycobacteria versus normal human
cells, towards which it is relatively non-toxic. This work suggests that photoactivatable prodrugs
such as 1 are potentially powerful new agents in combatting the global problem of antibiotic
resistance.Introduction
Antibacterial resistance (AMR) is a complex problem that
contributes to health and economic losses worldwide. Resistance
to antimicrobial therapies reduces the eﬀectiveness of currentarwick, Gibbet Hill Road, Coventry CV4
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Chemistry 2016drugs, leading to increased morbidity, mortality, and health care
expenditure. Because globalization increases the vulnerability of
any country to diseases occurring in other countries, resistance
presents a major threat to global public health.1 Mycobacteria,
such as Mycobacterium tuberculosis and Mycobacterium ulcerans,
are resistant to many antibiotics and their cell-wall structure is
believed to be largely responsible for the wide range of resistance
phenotypes.2 M. tuberculosis is a major cause of death worldwide,
and a formidable enemy infecting one third of the world. In 2014,
there were an estimated 9.6 million new TB infections worldwi-
de.1a By comparison, M. ulcerans causes Buruli ulcer (BU) and is
the third most important mycobacterial disease aer tubercu-
losis and leprosy worldwide. Furthermore, WHO reports that it is
endemic in West Africa as well as China and Australia, and its
geographic range is increasing.3a
Frequent and inappropriate use of antibiotics to treat TB has
resulted in the emergence of multidrug-resistant M. tuberculosis
(MDR TB) and extensive drug-resistant M. tuberculosis (XDR TB)
to front-line (isoniazid and rifampin) and second-line drugs
(amikacin, kanamycin and capreomycin).1a WHO recommenda-
tions for BU treatment, as with TB treatment, involve combina-
tion therapy (rifampicin, streptomycin or rifampicin,
clarithromycin). However, as therapy is rolled out, the emergence
of resistance is an inevitable outcome. Ineﬀective treatment oen
requires surgery, limb amputation, and sometimes results inChem. Sci.
Scheme 1 Stepwise photoactivation of the antibacterial prodrug cis-
[Ru(bpy)2(INH)2]
2+ (1). Ru(II) is blue, and Ru(III) is green.
Chemical Science Edge Article
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View Article Onlinedeath. Therefore, there is an urgent need to develop new drugs
and innovative strategies to tackle mycobacterial infections.
Considering the time-consuming discovery process and the
high mutation rate of Mycobacterium spp. to current antibiotics,
novel mechanisms for attack on bacteria are essential. In recent
years, photoactive therapy to combat cancer or bacterial infec-
tion has attracted increasing interest.4 Photoactive antimicrobial
therapy includes two kinds of therapy, photodynamic antimi-
crobial therapy (PDAMT)5 and photorelease antimicrobial
therapy (PRAMT).6 PDAMT and PRAMT are promising strategies
for treating surface bacterial infections, especially patients with
skin infection, scar tissues, burn infections, leg ulcers in dia-
betes patients, acne infection, and for sterilization of some
surfaces.7 PDAMT utilizes light and oxygen in combination with
a photosensitizer (PS).8 The ground state (GS) of the PS absorbs
visible light to reach a triplet excited state (ES) via intersystem
crossing and then generates the reactive oxygen species (ROS)
1O2, which is highly toxic and can cause non-specic damage to
bacterial cell components. PRAMT can control the time and
place of release of a therapeutic agent to achieve targeted therapy
and reduce systemic toxicity to host tissues.
Ruthenium(II) bipyridyl complexes can behave as eﬃcient
photoactivatable prodrug delivery systems, as shown by e.g.
Etchenique,9 Turro,10 Glazer11 and Gasser.12a,20 Recently, some
Ru(II) complexes have been studied for antibacterial activity.12
Ru(II) polypyridyl complexes containing extended aromatic
ligands are active against Gram-positive B. subtilis and S. aureus,
but inactive against Gram-negative E. coli.13 [Ru(bpy)2(NPDA)]
2+
(NPDA ¼ N-phenyl-substituted diazouorene) is active against
methicillin-resistant S. aureus (MRSA) and generates ROS to kill
MRSA.14 Some dinuclear Ru(II) complexes have been studied,
where rigid linkers between metal centers show lower activity
against S. aureus and E. coli compared to exible linkers.15 The
activity appeared to be linked to lipophilicity, as increased lip-
ophilicity results in increased penetration through cell
membranes and therefore increased uptake.16 Another strategy
used in the design of antibacterial agents is to attach an existing
organic antibacterial agent to a Ru(II) center, for example,
attachment of a b-lactam to a cyclopentadienyl ligand or using
ooxacin as a chelating ligand.17 This strategy can be used
either in an attempt to overcome resistance, or to achieve
a potential synergy between the metal and the antibacterial
agent. Currently there are few examples of Ru(II) complexes that
are being developed as anti-mycobacterial agents. Complexes
containing phosphine, diimine and picolinate groups have
shown promising activity against M. tuberculosis.18 They have
shown better activity than isoniazid against M. tuberculosis and
retain activity against an isoniazid-resistant strain.18b,c Here we
investigate the feasibility of using a potentially transformative
strategy to develop photoactive anti-mycobacterial drugs. We
have designed a photoactivatable Ru(II) complex that can
release an antimicrobial agent upon light irradiation. The
photoactivatable complex is based on cis-[Ru(bpy)2(INH)2]
2+,
where bpy is bipyridine and INH is isoniazid (anti-tuberculosis
compound). The aim of this study is to release the biologically
active isoniazid ligand by photoactivation and form a ruth-
enium(II) aqua species (Scheme 1). Encouragingly we found thatChem. Sci.complex 1 is selectively and potently active upon irradiation
towards the mycobacterium M. smegmatis.
Results and discussion
Chemical synthesis and structure
To synthesize 1$2PF6, cis-[Ru(bpy)2Cl2] and isoniazid (INH) were
heated in degassed water under nitrogen at 353 K for 6 h. The
solution was allowed to cool to ambient temperature and
NH4PF6 was added. The precipitate formed was collected by
ltration and washed sequentially with cold water and diethyl
ether. Crystals suitable for X-ray crystallography (Fig. S1a†) were
obtained by slow diﬀusion of 1,4-dioxane into a saturated
acetonitrile solution of 1$2PF6 at room temperature. The crystal
structure showed the presence of both enantiomers (D andL) in
the unit cell (Fig. S1†). The crystallographic data and selected
bond lengths and angles are given in Table S1 and S2.† The unit
cell contains pairs of enantiomers connected via a CH–p
interaction between CH of bpy from the D-complex and the p
system of INH from the L-complex (Fig. S1b†). The CH(bpy)-
centroid(INH) distance is 3.176 A˚ and the angle between the
ring planes is 81.76. There is a small twist angle of 3.29
between the pyridine rings of the bpy ligand. Each hydrazide
group on the INH ligand forms a hydrogen-bonded dimer that
links symmetry-related enantiomers forming an innite zigzag
chain. This is composed of a reciprocal interaction between the
hydrazide amide NH and the amine NH2 of the hydrazide of
a symmetry-related INH ligand related by an inversion centre
with an H-bond distance of N–H/N 2.199 A˚ (Fig. S1c†).
Photorelease analysis
Prior to investigating the photoactivity of the complex, it is
imperative to understand how the complex behaves in the dark.
The UV-visible spectra showed no appreciable change when
stored in aqueous solution over a 6 h period in the dark
(Fig. S2†). It was stable in the dark for the duration of the
experiment. When an aqueous solution (40 mM) of
cis-[Ru(bpy)2(INH)2]
2+ was exposed to blue light (lirr ¼ 465 nm,This journal is © The Royal Society of Chemistry 2016
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View Article Online20 mW cm2) at 298 K for <1 min, there were changes in the
UV-visible spectra (Fig. 1a). There was a red shi of the major
absorption band whereby the peak at 420 nm decreased and the
peak at 460 nm increased in intensity, producing an isosbestic
point at 450 nm. The presence of an isosbestic point suggested
that a stoichiometric reaction was occurring. In <1 min the
production of the photoproduct reached a plateau. The increase of
the peak at 460 nm with time followed a single exponential
relationship, as illustrated in Fig. 1, inset, which plots the change
in photoproduct absorbance (DAbs), at 460 nm, versus time.
Unsurprisingly, the time taken for the photoproduct to plateau in
DAbs was dependent on the wavelength of activation, given the
change in extinction coeﬃcient (Fig. S3†). Photoactivity was
observed upon exposure to radiation between 440 and 560 nm,
with the photoproductDAbs taking ca. 40 s to plateau upon 465 nm
light irradiation (Fig. 1, inset graph). There was no measurable
photoactivity upon irradiation with red light (lirr ¼ 610 nm).
Photoproduct analysis
In order to characterise the photoirradiation products fully,
liquid chromatography coupled to high resolution massFig. 1 UV-visible spectra of 40 mM cis-[Ru(bpy)2(INH)2]
2+ on photo-
irradiation with blue light (lirr ¼ 465 nm, 20 mW cm2), with kinetic
trace showing formation of the photoproduct (inset graph).
Table 1 Photoirradiation products detected and characterized by LC-H
Peak RT (min) MS (m/z)
A 7.4 344.0794
B 8.1 284.5553
C 3.2 128.0663
D 8.9 225.0306
E 4.3 224.5273
F 6.7 225.0304
This journal is © The Royal Society of Chemistry 2016spectrometry (LC-HRMS) was employed. An aqueous solution
(40 mM) of cis-[Ru(bpy)2(INH)2]
2+ was photoirradiated with blue
light (lirr ¼ 465 nm, 20 mW cm2) for 1 min, 30 min, 1 h and
2 h. The chromatogram at each timepoint of photoirradiation
and corresponding peaks in the high resolution mass spectrum
of each detected product peak are shown in Fig. S4† and Table
1, respectively. With no photoirradiation, there was only one
peak in the chromatogram (peak A) with a retention time of
7.4 min, corresponding to the starting material cis-[Ru(bpy)2-
(INH)2]
2+. Aer 1 min of photoirradiation, peak A was no longer
present and there were two new peaks at 8.1 min (peak B) and
3.2 min (peak C), which correspond to cis-[Ru(bpy)2(INH)-
(H2O)]
2+ and free INH, respectively. With increase in time of
photoirradiation, peak B decreased in intensity and peak C
increased in intensity. Aer 30 min of photoirradiation, there
were two new peaks at 8.9 min (peak D) and 6.7 min (peak F),
which correspond to the di-aqua photoproducts cis-[Ru(bpy)2-
(H2O)2]
2+ and trans-[Ru(bpy)2(H2O)2]
2+, respectively. Aer 1–2 h
photoirradiation, the aqua/hydroxido RuIII complex trans-
[Ru(bpy)2(H2O) (OH)]
2+ (peak E at 4.3 min) was detected; the
mass-to-charge ratio and isotopic models for peak E are
consistent with the formation of a Ru(III) species (Fig. S5†).
The photoproducts at the diﬀerent photoirradiated times all
appeared to be stable in solution, as there were no changes in
the UV-visible spectrum aer 1 h of incubation in the dark at
298 K (Fig. S6†). In addition, a solution of complex 1 in D2O and
photoirradiated with a blue LED for 1 min was monitored by
1H-NMR. Aer 1 min photoirradiation, the peaks assignable to
the starting material cis-[Ru(bpy)2(INH)2]
2+ decreased in inten-
sity and two new sets of peaks appeared. The rst set of 2 peaks
(8.68 ppm and 7.69 ppm) are due to the released free ligand
(INH), while the second set of peaks is assigned to the photo-
product cis-[Ru(bpy)2(INH)(D2O)]
2+ (Fig. S7†).
Photoactive studies on bacteria and mammalian cell
The photoactivity of complex 1 against Gram-positive, Gram-
negative and mycobacteria (B. subtilis, E. coli and M. smegmatis,
respectively) in vitro was compared using 96-array blue LED
(lirr ¼ 465 nm, 20 mW cm2) and 32-array multi-coloured LED
(lirr ¼ 465 nm (blue), 520 nm (green), 589 nm (yellow) and
625 nm (red), 5 mW cm2) irradiation. The designs for the LEDRMS (according to Fig. S4)
Formula calculated m/z Error (ppm)
Cis-[RuII(bpy)2(INH)2]
2+ 0.87
C32H30N10O2Ru: 344.0797
Cis-[RuII(bpy)2(INH)(H2O)]
2+ 0.70
C26H25N7O2Ru: 284.5555
[INH + H]+ 0.72
C6H7N3O: 138.0662
Cis-[RuII(bpy)2(H2O)2]
2+ 2.67
C20H20N4O2Ru: 225.0312
Trans-[RuIII(bpy)2(H2O) (OH)]
2+ 0.00
C20H19N4O2Ru: 224.5273
Trans-[RuII(bpy)2(H2O)2]
2+ 1.03
C20H20N4O2Ru: 225.0312
Chem. Sci.
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View Article Onlinearrays are shown in Fig. S8†. Firstly, cis-[Ru(bpy)2(INH)2]
2+ was
tested against Gram-positive B. subtilis and Gram-negative
E. coli models in the dark or photoirradiated for 2 h using the
96-array blue LED. The number of colony-forming units (CFU
mL1) was measured. For E. coli, the log10(CFU mL
1) was
found to be 7 for all concentrations (200 mM, 100 mM and
10 mM) both in the dark and upon photoirradiation. Addition-
ally, log10(CFUmL
1) for the control (cells not exposed to 1) and
for isoniazid alone (200 mM) was also 7 both in the dark and
aer photoirradiation (Fig. 2a). For B. subtilis and concentra-
tions of 200 mM and 100 mM 1, log10(CFU mL
1) was 6 in the
dark, and decreased to 3 when photoirradiated (Fig. 2b).
Log10(CFU mL
1) for the control and isoniazid alone (200 mM)
was 6 for both dark incubation and aer photoirradiation.
The photoactivity of 1 towards Mycobacterium smegmatis was
then investigated. When M. smegmatis was incubated with
cis-[Ru(bpy)2(INH)2]
2+ in the dark, the survival was 80%, 71%
and 65% for 10 mM, 30 mM and 50 mM complex 1, respectively.
However, aer 1 min, 30 min, 1 h and 2 h photoirradiation, the
survival was <1% at all these concentrations (Fig. S9†). The MIC
of 1 aer photoirradiation for 1 min (Fig. 2c) was found to be
4 mM. The minimum inhibitory concentration (MIC) for isoni-
azid alone is comparable to literature values (c.f. 29 mM).19
However, since the survival was >90% at a concentration of 4 mM
in the dark, the results suggest that the complex has a low
toxicity in the dark and high photocytotoxicity.
Then we determined the toxicity of 1 towards the (normal)
human lung cell line MRC-5. The complex was non-toxic, withFig. 2 Dose-response for INH alone or cis-[Ru(bpy)2(INH)2]
2+ (1) when
incubated with the 3 classes of bacteria (a) Gram-negative E. coli, (b)
Gram-positive B. subtilis, (c)M. smegmatis and (d) normal human lung
ﬁbroblast cell line MRC-5 in the dark (gray bars) or photoirradiated
(blue bars) using the 96-array blue LED (lirr ¼ 465 nm, 20 mW cm2)
for various times at 298 K. The survival at each photoirradiation
timepoint was compared to the light control in the absence of the
complex, while the survival for the complex in the dark was compared
to the dark control in the absence of complex. p values were calcu-
lated by comparing the light samples to the dark samples and are
labelled as follows, p # 0.05 ¼ *, p # 0.01 ¼ **.
Chem. Sci.survival levels of >90% at all concentrations tested, both in the
dark and upon irradiation with blue light (Fig. 2d). However,
when MRC-5 lung cells were incubated with 200 mM isoniazid
itself, the cell viability was only 60%. This suggests that
complex 1 has a high selectivity forM. smegmatis bacteria versus
normal human cells, a highly desirable property for a new
antibiotic. When M. smegmatis was photoirradiated using the
32-array of multi-colored LEDs for 30 min in the absence of the
complex, the survival was >90% for all wavelengths (blue, green,
yellow, and red; Fig. S10†). The dark survival of M. smegmatis
incubated with the complex was >90%. Aer M. smegmatis was
incubated with cis-[Ru(bpy)2(INH)2]
2+ in the dark for 1 h and the
samples were then photoirradiated for 30 min, survival
increased as the wavelength of photoirradiation increased: blue
0.3%, green 4%, yellow 94%, and red 96% (Fig. 3).TEAS, DFT and TD-DFT analysis
To further understand the photoactivity of 1, and in particular
the initial stage of photoactivation, we performed transient
electronic (UV-vis) absorption spectroscopy (TEAS). This tech-
nique has previously provided a detailed understanding of the
pathways involved in photoactivation of this type of RuII
complex.21,22 Eﬃcient population of a dissociative triplet metal-
centered (3MC) state is key to generating high quantum yields of
a penta-coordinate intermediate (PCI) species, which in turn
may form the target species: a mono-aqua photoproduct. We
showed that photoactivation of cis-[Ru(bpy)2(NA)2]
2+ to cis-
[Ru(bpy)2(NA) (H2O)]
2+ (NA ¼ nicotinamide) occurs with
a quantum yield $0.36, all within a timeframe of 400 ps.22
We performed TEAS to monitor the production of the mono-
aqua photoproduct and extract the timescales involved. Details
of the TEAS setup were as reported22 and as described in the
ESI.† An aqueous solution of 1 owing through a 950 mm path
length ow cell was photoexcited using a 340 nm (650 mW,Fig. 3 Activity of cis-[Ru(bpy)2(INH)2]
2+ against M. smegmatis when
incubated in the dark using the 32-array of multi-colored LEDs (lirr ¼
465 nm, 520 nm, 589 nm and 625 nm, 5 mW cm2) for 30 min. p
values were calculated by comparing the light and dark samples and
are labelled as follows, p # 0.05 ¼ *.
This journal is © The Royal Society of Chemistry 2016
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
0 
A
ug
us
t 2
01
6.
 D
ow
nl
oa
de
d 
on
 3
1/
08
/2
01
6 
15
:0
7:
50
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online2 mJ cm2) pump pulse and probed using a white light
continuum at pump-probe time delays ranging from 1 ps to
2 ns. The resulting transient absorption spectra (TAS) are shown
in Fig. 4a for selected time delays. The TAS at time delays
<500 ps comprise three distinct regions. From previous
studies23 and related literature,24 it is known that the feature at
360 nm is the absorption of the 3MLCT state which is
produced very shortly aer excitation (<100 fs) following inter-
system crossing from the initially populated 1MLCT state.
Comparison with the steady-state UV-visible absorption spectra
(see Fig. 1a) reveals the feature at 435 nm to be a ground state
bleach. The third feature, a broad absorption centred around
650 nm contains some contribution from the 3MLCT state, but
is mostly attributable to the PCI.22 For TAS at time delays
$500 ps a fourth feature is clearly visible 475 nm. Compar-
ison, once again with the steady-state UV-visible absorption
spectra indicates that this is absorption by the mono-aqua
(cis-[Ru(bpy)2(INH)(H2O)]
2+) photoproduct.
To obtain lifetimes of these features, we gathered kinetic
traces (5 nm-wide integrations around the indicated wave-
length) and tted themwithmono exponential functions. These
ts are shown in Fig. 4b. The summary of obtained lifetimes is
as follows: s3MLCT ¼ 207  10 ps, sGSB ¼ 231  7 ps, smono-aqua ¼
211  13 ps and sPCI ¼ 236  30 ps, the subscript pertaining to
the associated species. It should be noted that due to the
severity of the spectral overlap of the TAS features, there isFig. 4 (a) TAS of an 890 mM aqueous solution of 1 over pump-probe
time delays of 1 ps to 2 ns following excitation at 340 nm. Vertical
lines correspond to positions of kinetic traces. (b) Kinetic traces and
corresponding ﬁts for the four features as described in the main text.
This journal is © The Royal Society of Chemistry 2016contamination of signal in each of the kinetic traces (from
neighbouring features) and the extracted lifetimes will have
additional error that has not been accounted for. A more
rigorous treatment of these data necessitates a target or global
analysis to deconvolute the TAS.22
However the main objective of the present work was to
determine a timescale for the appearance of the mono-aqua
photoproduct, which we propose corresponds to <500 ps. We
also note that there is no evidence for the di-substituted
photoproduct, which is unsurprising, given that this is
a sequential process requiring the mono-aqua photoproduct to
absorb an additional photon.
Computational chemistry studies conrmed that
cis-[Ru(bpy)2(INH)2]
2+ displays a photochemical behaviour
typical of [Ru(bpy)2(L)2]
2+ scaﬀolds (where L ¼ monodentate
N-ligand, Fig. S11†), in agreement with our TEAS characteriza-
tion and previous experimental and theoretical work performed
on analogous systems.21,25
Singlet–singlet transitions calculated by time-dependent
density functional theory (TD-DFT) on the ground-state geom-
etry of 1 show the lowest energy bands (300–500 nm) in the
UV-visible spectrum and are predominantly of MLCT character
(Ru-bpy), whereas absorption peaks above 300 nm originate
from transitions with a signicant ligand (bpy) component
(Table S4 and Fig. S12†). Dissociative metal-centred (MC)
singlet transitions are accessible at ca. 350 nm and involve
Ru–N(INH) antibonding orbitals with strong Ru(d) character
(Fig. S13†). Analysis of triplet geometries further conrms the
prototypical behaviour of 1. Two low-lying triplets were opti-
mized, corresponding to the 3MLCT and 3MC states (spinFig. 5 DFT-optimized structures of the 3MLCT (yellow) and 3MC (light
green) states of 1 with (a) spin density surfaces (isovalue 0.0004) and
(b) their superimposition with the ground-state structure (violet) of the
complex.
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View Article Onlinedensity surfaces, Fig. 5 and Table S5†). The latter is 0.57 eVmore
stable than the 3MLCT state, hence it can be eﬀectively popu-
lated upon light excitation. Furthermore, one of the Ru–N(INH)
bonds is broken (3.79 A˚) in the 3MC state whichmay correspond
to the PCI detected by TEAS.
Conclusion
In conclusion, the antimicrobial activity of the photoactive
complex cis-[Ru(bpy)2(INH)2]
2+ was explored. Firstly, UV-visible
spectroscopy and HR-LCMS studies showed that irradiation
with blue or green light rapidly leads to the release of the
antibacterial ligand INH in aqueous media together with
formation of mono- and di-aqua adducts. Secondly,
cis-[Ru(bpy)2(INH)2]
2+ was inactive against the Gram-negative
bacterium E. coli and showed only slight activity once photo-
irradiated with blue light for 2 h against the Gram-positive
bacterium B. subtilis at concentrations of 100 mM and 200 mM.
The high photoactivity of 1 was evident from its high potency
towards the mycobacterium M. smegmatis with an MIC value of
4 mM aer only 1 min of photoirradiation with blue light. This
was a 5.5 increase in potency compared to isoniazid alone.
The survival of the bacteria incubated with the complex in the
dark is >80% at the MIC value, showing that the active ligand
(isoniazid) was successfully released only upon photo-
irradiation. Activation of the complex in cells was optimum for
blue (465 nm) and green (520 nm) light irradiation, but no
activation was observed with yellow or red light. Complemen-
tary pump-probe spectroscopy measurements have shown that
the mono-aqua photoproduct is formed in <500 ps, potentially
mediated by a 3MC state, which, as DFT calculations show, has
antibonding character along the Ru–INH bond. If longer
wavelengths are required for deeper tissue penetration, then
activation may be achievable with two-photon methods, which
are currently being explored in our laboratory.
These results suggest that the photoactivatable prodrug
cis-[Ru(bpy)2(INH)2]
2+ might provide a promising new strategy
for combatting antibiotic resistance. Importantly we have
shown that this complex is highly selective for killing myco-
bacteria as opposed to normal human cells. New drugs for
combatting mycobacterial infections are in very high demand.
Phototherapy using ruthenium complexes such as 1 is likely to
be more successful for surface infections where topical
administration is facile and the light does not have to penetrate
deeply. Hence a target for treatment might be Buruli ulcer,
a somewhat neglected and progressively destructive skin
disease caused by Mycobacterium ulcerans which is endemic in
West Africa, China, Australia and spreading.3a The huge scale of
such infections means that novel approaches to therapy such as
that described here are crucial for exploration.
Experimental section
Materials
Cis-[Ru(bpy)2Cl2] (bpy ¼ 2,20-bipyridine) was synthesised as
described.26 Isoniazid (INH) and NH4PF6 were purchased from
Sigma-Aldrich and used without further purication. TheChem. Sci.solvents used for UV-visible absorption spectroscopy were
reagent grade. The NMR spectroscopy solvent DMSO-d6 was
purchased from Cambridge Isotope Laboratories Inc and D2O
was purchased from Sigma-Aldrich. Middlebrook 7H9 Broth
Base, glycerol, dextrose, sodium chloride, bovine serum
albumin, Tween® 80, phosphate-buﬀered saline tablets and
tryptic soy broth were purchased from Sigma Aldrich. The
bacteria, B. subtilis 168 and E. coli C43 (DE3), were kindly
provided by Mrs Anne Smith from the Chemical Biology Labo-
ratory, Department of Chemistry, University of Warwick. The
M. smegmatis was obtained from the National Collection of Type
Cultures (NCTC). The normal lung broblast cell line (MRC-5)
was purchased from ATCC and cultured in DMEM medium
(Gibco) supplemented with FCS (10%; Gibco), penicillin (100
U mL1), and streptomycin (100 mg mL1) in a humidied
atmosphere at 37 C and 5% CO2.
Instrumentation
1H NMR spectra were recorded on a Bruker AV-400 spectrom-
eter. Elemental analysis was performed by Exeter Analytical
using a CHN/O/S Elemental Analyser (CE440). Positive ion
ESI-MS spectra were obtained using an Agilent 6130B single
quad coupled to an automated sample delivery system (isocratic
Agilent 1100 HPLC without column). LC-HRMS analysis was
carried out with a Dionex 3000RS UHPLC coupled to a Bruker
MaXis Q-TOF mass spectrometer. UV-visible absorption spectra
were recorded on a Varian Cary 300 UV-vis spectrophotometer
tted with an external Varian Cary temperature controller.
X-ray crystallographic data collection and processing
Crystal data were collected on an Oxford Diﬀraction Gemini
four-circle system with Ruby CCD area detector at ambient
temperature (293(2) K). Maximum theta was 70.68 deg. The hkl
ranges were 24/26, 19/19, 23/17. 14 874 reections
measured, 4773 unique [R(int) ¼ 0.0329]. Absorption correction
was semi-empirical from equivalent reections; minimum and
maximum transmission factors: 0.56; 1.00.
Structure analysis and renement
Systematic absences indicated space group C2/c or Cc. The
former was chosen on the basis of intensity statistics and shown
to be correct by successful renement. The structure was solved
by direct methods using SHELXS (Sheldrick, 1997) (TREF) with
additional light atoms found by Fourier methods. Hydrogen
atoms were added at calculated positions and rened using
a riding model. Anisotropic displacement parameters were used
for all non-H atoms; H-atoms were given isotropic displacement
parameters equal to 1.2 times the equivalent isotropic
displacement parameter of the atom to which the H-atom is
attached.
The asymmetric unit contains half an Ru, a bipy and a pyr-
idylhydrazide, a PF6 counter ion and some dioxane solvent. The
Ru sits on a two-fold axis. The hydrazide group on the pyridyl
was modelled as disordered over two positions. The occupancy
factors rened to 50 : 50. The amide hydrogen of these hydra-
zide groups was placed at a calculated position using AFIX 43.This journal is © The Royal Society of Chemistry 2016
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View Article OnlineThe two hydrogens on the terminal NH2 were located in
a diﬀerence map and rened with DFIX and DANG restraints
and given thermal parameters of 1.2 times the equivalent
isotropic displacement parameter of the nitrogen to which they
are attached. The PF6 was modelled as disordered about the
central meridian and rened to an occupancy of 59 : 41major to
minor. There were several molecules of dioxane in the crystal.
These were very disordered.
Dioxane O20–C25 was modelled at half occupancy. Dioxane
O20A–C25A was modelled at 0.25 occupancy and was situated
roughly on the same position as dioxane O20–C25. Dioxane
O20B–C25B was disordered about a two-fold axis and so was
rened at half occupancy under a PART-1 in Shelxl. No hydro-
gens were placed on the minor component dioxane O20A-C25A
but these were included in the formula for completeness. Many
DFIX, DANG and SIMU restraints were used to give these
disordered components reasonable bond lengths, bond angles
and thermal parameters. All the disordered components were
rened isotropically. The hydrazine forms an H-bonded dimer
with the neighbouring hydrazide of a symmetry-related complex
(across inversion centre).
X-ray crystallographic data for 1 have been deposited in the
Cambridge Crystallographic Data Centre under the accession
number CCDC 1474453.
Light sources
The output of the KiloArc™ and LED light sources was moni-
tored using an International Light Technologies Powermeter
(ILT1400-A) equipped with SEL 033 detector and at response
visible lter F/W (400–1064 nm).
The complex was tested against bacteria using the 96-array of
blue LEDs (lirr¼ 465 nm, 20 mW cm2) or the 32-array of multi-
coloured LEDs (lirr ¼ 465 nm, 520 nm, 589 nm and 625 nm,
5 mW cm2). The 96- and 32-array multi-colored LEDs were
constructed by Mr Rod Wesson, Electrical and Electronics
Workshop, Department of Chemistry, University of Warwick.
Pictures of the designed LED setups are shown in Fig. S8.† The
96-array LEDs used were Multicomp OVL-5523 5 mm LEDs with
a dominant wavelength of 465 nm and a power of 20 mW cm2
once constructed into the array. The 32-array of multi-colored
LEDs used were Multicomp OVL-5523 5 mm (dominant wave-
length of 465 nm), Multicomp OVL-5524 5 mm (dominant
wavelength of 520 nm), Multicomp OVL-5526 5 mm (dominant
wavelength of 589 nm) and Multicomp OVL-5528 5 mm
(dominant wavelength of 625 nm) with a power of 5 mW cm2
once constructed into the array. The change in optical density
(OD) of a bacterial suspension at 600 nm was monitored using
Thermo Labsystems IEMS MF microplate reader with a 96-well
plate.
Synthesis of cis-[Ru(bpy)2(INH)2][PF6]2 (1)
Cis-[Ru(bpy)2(Cl)2] (104 mg, 0.2 mmol) and isoniazid (INH)
(137 mg, 1 mmol) in 15 mL water were reacted under nitrogen at
353 K for 6 h. The solution was allowed to cool to room
temperature and ltered to remove any unreacted starting
material. Then NH4PF6 (163 mg, 1 mmol) was added to giveThis journal is © The Royal Society of Chemistry 2016a precipitate. The precipitate was collected by ltration and
washed with cold water and diethyl ether. Yield: 66% (130 mg,
0.1 mmol). Elemental analysis calculated for C32H30F12N10O2-
P2Ru$2H2O, %C: 37.92, %H: 3.38, %N: 13.82; found %C: 37.99,
%H: 3.07,%N: 13.35. ESI-MS calculated for C32H30N10O2Ru [M]
2+
m/z 344.1, found m/z 343.9. 1H-NMR (DMSO-d6, 400 MHz) d H:
4.7 (4H, NH2), 7.5 (2H, t, J ¼ 6.4 Hz), 7.6 (4H, d, J ¼ 6.7 Hz), 7.9
(2H, t, J ¼ 6.5 Hz), 7.9 (2H, d, J ¼ 5.1 Hz), 8.0 (2H, t, J ¼ 7.5 Hz),
8.2 (2H, t, J ¼ 7.3), 8.5 (4H, d, J ¼ 6.4 Hz), 8.6 (2H, d, J ¼ 8.3 Hz),
8.7 (2H, d, J ¼ 7.8 Hz), 9.0 (2H, d, J ¼ 5.4 Hz), 10.2 (2H, NH).
Crystals of cis-[Ru(bpy)2(INH)2][PF6]2$2.5(dioxane) suitable
for X-ray crystallography were obtained from slow diﬀusion of
1,4-dioxane into a saturated acetonitrile solution of 1 at
ambient temperature.
Photoirradiation followed by LC-HRMS
Cis-[Ru(bpy)2(INH)2][PF6]2 was dissolved in deionised water to
give a complex concentration of 40 mM. The solution (400 mL)
was placed into a 1 cm path-length quartz cuvette and irradiated
using a blue LED light source (lirr ¼ 465 nm, 20 mW cm2) at
298 K for various times. The sample was diluted with deionised
water and injected into the LC-HRMS instrument. The mobile
phases consisted of A (water with 0.1% triuoroacetic acid) and
B (ACN with 0.1% triuoroacetic acid). A gradient of 10% B
(0 min), 80% B (30 min) was employed with a ow rate of
1 mL min1 and UV detection at 254 nm.
Photoirradiation followed by 1H-NMR spectroscopy
Cis-[Ru(bpy)2(INH)2][PF6]2 was dissolved in D2O to give
a complex concentration of 6 mM and placed in a 5 mm o.d.
NMR tube. The sample was photoirradiated using a blue LED
(lirr ¼ 465 nm, 20 mW cm2) at 298 K for various times. The
1H-NMR spectrum of each sample was recorded on a Bruker
AV-400 spectrometer at 298 K. Data processing was carried out
using Bruker Topspin 2.1.
Photoactivity against bacteria and mammalian cell
The tryptic soy broth (TSB) and phosphate-buﬀered saline (PBS)
were prepared as per manufacturer's instructions. An overnight
culture of E. coli in TSB was centrifuged and the cell pellet was
re-suspended in PBS to give a nal OD of 0.015. The E. coli
suspension was added to wells in a black 96-well plate (100 mL).
Cis-[Ru(bpy)2(INH)2][PF6]2 dissolved in PBS was added to the
wells (100 mL) to give nal complex concentrations of 200 mM,
100 mM and 10 mM. In the dark and light control wells only PBS
(100 mL) was added. Each well was prepared in triplicate. Two
black 96-well plates were prepared; one for photoirradiation
and one for the dark controls. Both black 96-well plates were
incubated initially in the dark for 3 h at 298 K. Subsequently,
one of the black 96-well plates was photoirradiated using the
96-array blue LED (lirr ¼ 465 nm, 20 mW cm2) at 298 K for 2 h,
while the other black 96-well plate was kept in the dark. The
contents of each well (100 mL) were plated onto TSB agar plates
and incubated overnight at 310 K. Aer incubation the number
of colony forming units (CFU mL1) were counted. The same
procedure was performed using B. subtilis. The student's t-testChem. Sci.
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View Article Onlinewas performed with two-tail distribution and unequal variance
to determine p values (*denotes p # 0.05 while **denotes p #
0.01); the light samples were compared to the dark samples.
Photoactivity against M. Smegmatis using 96-array of blue
LEDs and 32-array of multi-colored LEDs. Prior to use, the
M. smegmatis stock suspension was diluted to OD 0.002 with 7H9
media.27 The resulting solution was placed into wells of a black
96-well plate (100 mL). The complex cis-[Ru(bpy)2(INH)2][PF6]2
was dissolved in 7H9medium and added to the wells (100 mL) to
give various nal complex concentrations. In the dark and light
control wells only 7H9 medium (100 mL) was added. Each well
was prepared in triplicate. Two black 96-well plates were
prepared. Both black 96-well plates were incubated initially in
the dark for 1 h at 298 K. Subsequently, one of the black 96-well
plates was irradiated using the 96-array blue LED (lirr¼ 465 nm,
20 mW cm2) for various times of irradiation, while the other
black 96-well plate was kept in the dark. The contents of both
black 96-well plates were transferred to a clear 96-well plate
which was placed into a Thermo Labsystems IEMS MF micro-
plate reader. The growth of M. smegmatis was monitored by
measuring the change in OD at 600 nm at 310 K over 72 h. The
percentage survival was calculated by comparing the values ob-
tained to the appropriate control; light exposed samples were
compared to the light control and the dark samples were
compared to the dark controls. The student's t-test was per-
formed with two-tail distribution and unequal variance to
determine p values (*denotes p# 0.05 while **denotes p# 0.01).
The minimum inhibitory concentration (MIC) is dened at the
minimum concentration that produced <5% survival of bacteria.
The same procedure as above used the 32-array of multi-colored
LEDs (lirr¼ 465 nm, 520 nm, 589 nm and 625 nm, 5 mW cm2).
Photoactivity against human lung cell MRC-5 was tested
using the 96-array of blue LEDs. The normal lung cell MRC-5
solution was placed into two black 96-well plates (100 mL).
Complex 1 was dissolved in DMEMmedium with 1% DMSO and
added to the wells (100 mL) to give various nal concentrations.
In the dark and light control wells only DMEM medium was
added. Each well was prepared in triplicate. Two black 96-well
plates were incubated initially in the dark for 1 h in the incu-
bator. Subsequently, one of the black 96-well plates was irradi-
ated using the 96-array blue LED (lirr ¼ 465 nm, 20 mW cm2)
for 1 min, while the other black plate was kept in the dark. Then
the cells were incubated for another 72 h in the incubator. The
cell viability of MRC-5 cells was monitored using a MTTmethod.
The contents of two plates were transferred to clear 96-well plates
which were placed into a Promega microplate reader.Transient electronic (UV-vis) absorption spectroscopy
A solution of 1 was delivered using a steel ow-through cell
(Harrick Scientic), equipped with two CaF2 windows and
a 950 mm thick Teon spacer, which denes the optical path
length. The sample was recirculated using a peristaltic pump
(Masterex) with PTFE tubing throughout, at a ow speed
suﬃcient to ensure a fresh solution was sampled with each laser
shot. Sample was excited using 340 nm, 80 fs pump pulses.
The pump beam was focused 10 mm behind the sample toChem. Sci.ensure a beam waist at the sample of250 mm (5 times that of
the probe) and return pump uences of 1–2mJ cm2. The use of
a 500 Hz mechanical chopper (Thorlabs) in the pump beam
created alternating pumped and non-pumped sample spectra
from which a diﬀerence spectrum may be calculated. Pump–
probe delays (up to 2 ns) were created using a motorized optical
delay line in the probe beam path. The pump and probe pulses
were generated from a commercially available femtosecond
Ti-sapphire regenerative amplied laser system operating at
1 kHz and producing 3mJ pulses. The output of the laser system
(SpectraPhysics, Spitre XP) was split equally to give three
800 nm beams (1 mJ per pulse each), two of which were used in
the present measurements. One of the beams was used to pump
an optical parametric amplier (OPA) (Light-Conversion,
TOPAS) to generate 340 nm pump pulses. The second beam was
used to generate the broadband white light continuum (340 to
675 nm) probe pulses, by focusing <5% of this 1 mJ per pulse
beam into a vertically translated CaF2 window. This beam was
detected using a bre coupled UV/vis spectrometer (Avantes,
AvaSpec-ULS1650F-USB2). Probe polarisation was held at the
magic angle (54.7) relative to the pump polarisation.Computational analysis
All calculations were performed using Gaussian 03. Becke's
three-parameter hybrid functional28 with the Lee–Yang–Parr's
gradient-corrected correlation functional29 (B3LYP) was used
with LanL2DZ basis set30 and eﬀective core potential for the
ruthenium atom, and the split valence 6-31G** basis set31 for all
other atoms. Geometry optimisations of the ground state (S0)
and the lowest-lying triplet state (T1) were performed in the gas
phase and the nature of all stationary points was conrmed by
normal mode analysis. For the lowest-lying triplet states, the
unrestricted Kohn–Sham method (UKS) was utilised with
unrestricted B3LYP functional (UB3LYP). The electronic struc-
ture and excited states in solution were calculated using the
conductor-like polarisable continuum model method32 (CPCM)
with water as the solvent. Fiy singlet excited states (with cor-
responding oscillator strengths) and sixteen triplet excited
states (starting from the lowest-lying triplet state geometry) were
calculated by time-dependent density functional theory
(TD-DFT).33 The electronic distribution and localization of the
excited states were assigned using GaussSum 2.2.5.34Conﬂict of interest
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